Novo Nordisk surged 7.1% at the end of Tuesday, after the company's Wegovy diet pills were approved by the US Food and Drug Administration, boosting the prospects of the weight loss market.

Zhitongcaijing · 1d ago
Novo Nordisk surged 7.1% at the end of Tuesday, after the company's Wegovy diet pills were approved by the US Food and Drug Administration, boosting the prospects of the weight loss market.